• Abstracts will be accepted in English only
• All abstracts must not exceed 500 words
• A table or figure will count as 150 words
• The total word count does not include the title, authors’ details or references
• The name of the presenting author must appear first in the list of authors
• An international panel of reviews will review all abstracts anonymously
• There is no fee for submitting an abstract
• There is no limit to the number of poster abstracts you may submit
• CINP recommends using the NbN nomenclature for psychotropics (http://nbn2r.com)

Abstract submissions must be structured with the following:

• Background
• Aims & Objectives
• Method
• Results
• Discussion  & Conclusion
• References – Use Harvard style, where each reference is numbered in order of use
• Keywords – Mandatory to include three

• Oral Presentation: A limited number of abstracts will be selected as 15-min oral presentations (12 minutes presentation plus 3 minutes of Q&A) in one of the Oral Abstract sessions. If you are not comfortable providing an oral presentation, please only select poster presentation during submission.
• Poster Presentation: Abstracts not selected for oral presentation will be provided a poster presentation. Top rated posters will be selected as 5-minute presentations (3 minutes presentation plus 2 minutes Q&A) in one of the Data Blitz sessions.

The CINP International Scientific Programme Committee welcomes abstracts that link the latest, and ground-breaking, preclinical developments with the clinical research on a given topic. Through the free and open exchange of ideas, CINP supports a strong focus on new approaches to the development and assessment of CNS pharmaceuticals by researchers working in both academia and industry. 

Please find below the list of topics: